Ultragenyx Experiences Inducement Grant Beneath Nasdaq Itemizing Rule 5635(c)(4) By Investing.com
NOVATO, Calif., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ:…
Fed’s Daly says it’s time to contemplate adjusting borrowing prices, FT studies By Reuters
(Reuters) - San Francisco Federal Reserve Financial institution President Mary Daly mentioned…
atai stories constructive Part 1b outcomes for despair remedy By Investing.com
NEW YORK and BERLIN – atai Life Sciences (NASDAQ: ATAI), a biopharmaceutical…
Earnings name: InspireMD experiences progress and anticipates US launch By Investing.com
InspireMD (NASDAQ:), Inc. (NYSE American: NSPR), a medical gadget firm, reported a…
Earnings name: CCL Industries experiences sturdy Q2 development, cautious outlook By Investing.com
CCL Industries Inc. (CCL), a world chief in specialty label and packaging…
Earnings name: Embecta stories Q3 income dip, raises steerage By Investing.com
Embecta (ticker: EMBC), a number one medical expertise firm, reported a income…
Earnings name: Phunware experiences development and strategic enlargement in Q2 2024 By Investing.com
Phunware, Inc. (NASDAQ: PHUN), a number one cellular functions platform supplier, has…
Earnings name: Kura Oncology reviews progress with ziftomenib in Q2 2024 By Investing.com
Kura Oncology (NASDAQ:) has supplied a complete replace throughout its second quarter…
Earnings name: Joint Company studies development and strategic initiatives in Q2 By Investing.com
Within the current earnings name for the second quarter of 2024, Joint…
Earnings name: Barings BDC experiences steady earnings and a internet asset worth per share of $11.36 By Investing.com
Barings BDC, Inc. (NYSE:) has disclosed its monetary outcomes for the quarter…
